Find out if you are eligible through our online assessment
Semaglutide: Offered in both injectable and oral forms, Semaglutide boasts greater potency and a much longer half-life (~170 hours) than Liraglutide, making it a favored choice for weight management
But what will a small jab do to you
The clinical data from ESSENCE showed that at week 72, 36.8% of people treated with Wegovy achieved improvement in liver fibrosis with no worsening of steatohepatitis compared to 22.4% treated with placebo
A personalised, risk-stratified approach that optimises nutrition, encourages physical activity, and monitors high-risk patients ensures that the considerable benefits of GLP-1 receptor agonist therapy can be realised whilst maintaining skeletal health
This approach maximizes benefits while reducing the amount of medication you need when appropriate